Comparison of Sodium Hypochlorite Gel and Solution With and Without Nanoparticles for Postoperative Pain After Pulpotomy in Permanent Mandibular Molars
NaOCl Pulpotom
Comparative Evaluation of Sodium Hypochlorite Gel and Solution, With and Without Nano-particles, on Post-operative Pain Following Pulpotomy in Permanent Mandibular Molar Teeth; "Randomized Clinical Trail"
1 other identifier
interventional
60
1 country
1
Brief Summary
This randomized clinical trial aims to compare the effect of 2% sodium hypochlorite gel and solution, with and without chitosan nanoparticles, on postoperative pain following pulpotomy in mature permanent mandibular molars with symptomatic irreversible pulpitis. Participants will be randomly allocated into four parallel groups receiving either 2% sodium hypochlorite solution, 2% sodium hypochlorite gel, 2% sodium hypochlorite solution containing chitosan nanoparticles, or 2% sodium hypochlorite gel containing chitosan nanoparticles as the haemostatic agent during pulpotomy. Postoperative pain will be assessed using an 11-point Numerical Rating Scale at 6, 12, 24, and 72 hours and 7 days after treatment. The study will also evaluate the overall clinical and radiographic success of pulpotomy during follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedFirst Submitted
Initial submission to the registry
August 10, 2026
CompletedFirst Posted
Study publicly available on registry
August 19, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
ExpectedAugust 19, 2026
August 1, 2026
1 month
August 10, 2026
August 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Post-operative pain
• Postoperative pain reported by the patient after pulpotomy in both groups is to be recorded by NRS (Numerical Rate Scale). Scale from 0-10 recorded every 24hours until the seventh day. The NRS for pain is a straight line with one end (point 0) meaning no pain and the other end (point 10) meaning the worst pain imaginable.
Pain will be recorded preoperative and after 6hours, 12hours, 24hours, 72hours and one week using numerical rate scale (NRS).
Secondary Outcomes (1)
Clinical and Radiographic Overall success
3, 6, 12, months
Study Arms (4)
Intervention 1
EXPERIMENTALvital pulp therapy with NaOCL gel 2%.
Intervention 2
EXPERIMENTALvital pulp therapy with NaOCL solution 2% incorporated with nano-particles
Intervention 3
EXPERIMENTALvital pulp therapy with NaOCL gel 2% incorporated with nano-particles.
Control
EXPERIMENTALVital pulp therapy with NaOCL solution 2% .
Interventions
The procedures will be performed under local anesthesia with Lidocaine 2% and adrenaline 1/100,000. Teeth will be isolated with rubber dam. Caries will be completely removed with a sterile diamond stone (size 2). The access cavity will be prepared up to the level of pulp chamber floor using sterile round diamond bur size 2 in high-speed hand piece with coolant. Once the pulp has been reached, a sharp sterile spoon excavator should be used to remove the pulp tissue to the level of the radicular pulp. Hemostasis will be achieved by a small cotton pellet socked with agent, the teeth will be then divided into 4 groups depending on the pulpotomy agents into; • Group A which will be the intervention group and hemostasis is NaOCL gel 2%.
The procedures will be performed under local anesthesia with Lidocaine 2% and adrenaline 1/100,000. Teeth will be isolated with rubber dam. Caries will be completely removed with a sterile diamond stone (size 2). The access cavity will be prepared up to the level of pulp chamber floor using sterile round diamond bur size 2 in high-speed hand piece with coolant. Once the pulp has been reached, a sharp sterile spoon excavator should be used to remove the pulp tissue to the level of the radicular pulp. Hemostasis will be achieved by a small cotton pellet socked with agent, the teeth will be then divided into 4 groups depending on the pulpotomy agents into; • Group B which will be the intervention group and hemostasis is NaOCL gel 2% with chotosan nanoparticles
The procedures will be performed under local anesthesia with Lidocaine 2% and adrenaline 1/100,000. Teeth will be isolated with rubber dam. Caries will be completely removed with a sterile diamond stone (size 2). The access cavity will be prepared up to the level of pulp chamber floor using sterile round diamond bur size 2 in high-speed hand piece with coolant. Once the pulp has been reached, a sharp sterile spoon excavator should be used to remove the pulp tissue to the level of the radicular pulp. Hemostasis will be achieved by a small cotton pellet socked with agent, the teeth will be then divided into 4 groups depending on the pulpotomy agents into; • Group C which will be the intervention group and hemostasis is NaOCL solution 2% with chitosan nanoparticles
The procedures will be performed under local anesthesia with Lidocaine 2% and adrenaline 1/100,000. Teeth will be isolated with rubber dam. Caries will be completely removed with a sterile diamond stone (size 2). The access cavity will be prepared up to the level of pulp chamber floor using sterile round diamond bur size 2 in high-speed hand piece with coolant. Once the pulp has been reached, a sharp sterile spoon excavator should be used to remove the pulp tissue to the level of the radicular pulp. Hemostasis will be achieved by a small cotton pellet socked with agent, the teeth will be then divided into 4 groups depending on the pulpotomy agents into; • Group D which will be the intervention group and hemostasis is NaOCL solut 2%.
Eligibility Criteria
You may qualify if:
- Patients suffering from Symptomatic irreversible pulpitis in mature mandibular molars.
- Patients of either gender aged from 15-40.
- Patients free from any systemic disease that may affect normal healing and predictable outcome.
- Patients who will agree to the consent and will commit to follow-up period.
- Patients with mature root.
- Patients with no internal or external resorption and no periapical lesions.
- Tooth give positive response to sensitivity test.
- Tooth is restorable and free from advanced periodontal disease, cracks and splits.
- Hemostasis achieved after total pulpotomy.
- Soft tissues around the tooth are normal with no swelling or sinus tract.
You may not qualify if:
- Hemostasis after 10 minutes can not be controlled after total pulpotomy.
- Patients with immature roots.
- Patients with any systemic disease that may affect normal healing.
- Patients with periapical lesions or infections.
- Pregnant females.
- Patients who could/would not participate in a 6 months follow-up.
- Patients with fistula or swelling
- Patients with necrotic pulp.
- Patients with old age.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University
Cairo, 11511, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dentist
Study Record Dates
First Submitted
August 10, 2026
First Posted
August 19, 2026
Study Start
March 1, 2026
Primary Completion
April 1, 2026
Study Completion (Estimated)
March 1, 2027
Last Updated
August 19, 2026
Record last verified: 2026-08